Oxford, United Kingdom

Matthew John McCourt

This inventor holds 1 USPTO granted patent. Top assignee: British Biotech Pharmaceuticals Limited. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew John McCourt. Retrieved from https://idiyas.com/inventor/matthew-john-mccourt-wl8ein4n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthew John McCourt: Innovator in Hematopoietic Cell Mobilization

Introduction

Matthew John McCourt is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the area of hematopoietic cell mobilization. His innovative work has led to the development of a patent that addresses important medical challenges.

Latest Patents

Matthew holds a patent titled "Release and mobilization of haematopoietic cells." This patent represents his commitment to advancing medical science and improving patient outcomes. He has successfully secured 1 patent that showcases his expertise and dedication to innovation.

Career Highlights

Matthew is currently employed at British Biotech Pharmaceuticals Limited, where he continues to work on groundbreaking projects. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Matthew has worked alongside esteemed colleagues, including Michael Berisford Comer and Lars Michael Wood. These collaborations have enriched his research and development efforts, fostering an environment of innovation and creativity.

Conclusion

In summary, Matthew John McCourt is a distinguished inventor whose work in hematopoietic cell mobilization has made a significant impact in the field of biotechnology. His patent and collaborations reflect his commitment to advancing medical science and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…